Paper in Nature Protocols

“Cardiac differentiation of human pluripotent stem cells in scalable suspension culture”, Nature Protocols 2015

In August 2015, five LEBAO scientists conjointly released a publication in the renowned journal Nature Protocols (impact factor 2015: 9,646). Cardiomyocytes based on human pluripotent stem cells are not only a promising potential cell source for regenerative therapies but also for the search for novel drugs as well as the development of disease models. For these purposes, appropriate amounts of cells are required. The two first authors Christina Kropp and Henning Kempf have taken up this mission: The scientists developed a protocol based on suspension cultures that allows for an upscaling of cardiomyocyte production

Kempf, H.*, Kropp, C.*, Olmer, R., Martin, U., and Zweigerdt, R. 2015. Cardiac differentiation of human pluripotent stem cells in scalable suspension culture. Nature Protocols 10, no. 9:1345. *Authors contributed equally.